---
title: "HADDEN JOHN — Ownership Dossier"
canonical: https://whiteintel.dev/entity/0610abc8-36d7-5dfa-bcaf-1e50a4e56194
json: https://whiteintel.dev/api/public/dossier/0610abc8-36d7-5dfa-bcaf-1e50a4e56194
identifier: sec:0001189592
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# HADDEN JOHN

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001189592`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/0610abc8-36d7-5dfa-bcaf-1e50a4e56194  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/0610abc8-36d7-5dfa-bcaf-1e50a4e56194  

## Ownership & control

### Holdings / subsidiaries

- **DIPEXIUM PHARMACEUTICALS, INC.** (director) — https://whiteintel.dev/entity/922c9187-01ca-52f3-9a7a-455b0e76e092

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **HADDEN JOHN**. Human view: https://whiteintel.dev/entity/0610abc8-36d7-5dfa-bcaf-1e50a4e56194 · Structured JSON: https://whiteintel.dev/api/public/dossier/0610abc8-36d7-5dfa-bcaf-1e50a4e56194._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._